Nome del prodotto |
compactin |
Nome inglese |
compactin; Mevastatin; 2-Methyl-butanoic acid [1S-[1-alpha(R*),7-beta,8-beta(2S*,4S*),8a-beta]]-1,2,3,7,8,8a-hexahydro-7-methyl-8-[2-(tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl)ethyl]-1-naphthalenyl ester; ML-236B; (1S,7S,8S,8aR)-8-{2-[(2R,4R)-4-hydroxy-6-oxotetrahydro-2H-pyran-2-yl]ethyl}-7-methyl-1,2,3,7,8,8a-hexahydronaphthalen-1-yl (2S)-2-methylbutanoate; [(1S,7S,8S,8aR)-8-[2-[(2R,4S)-4-hydroxytetrahydropyran-2-yl]ethyl]-7-methyl-1,2,3,7,8,8a-hexahydronaphthalen-1-yl] (2S)-2-methylbutanoate |
Formula molecolare |
C23H34O5 |
Peso Molecolare |
390.5199 |
InChI |
InChI:1S/C23H34O5/c1-4-14(2)23(26)28-20-7-5-6-16-9-8-15(3)19(22(16)20)11-10-18-12-17(24)13-21(25)27-18/h6,8-9,14-15,17-20,22,24H,4-5,7,10-13H2,1-3H3 |
Numero CAS |
73573-88-3 |
Struttura molecolare |
|
Densità |
1.13g/cm3 |
Punto di fusione |
151-153℃ |
Punto di ebollizione |
555 °C at 760 mmHg |
Punto d'infiammabilità |
186.5 °C |
Solubilità in acqua |
DMSO: 20 mg/mL |
Simboli di pericolo |
|
Codici di Rischio |
|
Sicurezza Descrizione |
|
|